EBGLYSS is an FDA-approved drug for treating moderate-to-severe eczema by targeting IL-13, offering relief to patients ...

The Food and Drug Administration had recently approved a new drug for the treatment of atopic dermatitis (eczema), which can ...

Millions of Aussies can get a free vaccination for painful and debilitating shingles. People who are classified as 'moderate to high risk' aged between 18- 64 now qualify for the immunisation.

Headaches that present to an ophthalmologist include migraine, facial pain syndromes, and pain associated with cranial neuropathies, orbital, and ocular disease. Some headaches are symptoms of ...

Shingles generally lasts about three to five weeks. The rash associated with shingles usually crusts over within seven to 10 days for people with a healthy immune system and then clears up within two ...